Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Treating high-risk myeloma in the elderly

Ashley Elizabeth Rosko • 1 Jun 2019
ASCO 2019
Multiple Myeloma

Many challenges present themselves in the treatment of myeloma in the geriatric population. Ashley Elizabeth Rosko, MD, from Ohio State University, Columbus, OH, discusses these challenges and how to improve treatment outcomes in these patients at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Ashley Elizabeth Rosko

2:40
Improving the management of geriatric myeloma
Ashley Elizabeth Rosko • 1 Jun 2019
1:52
Managing myeloma in geriatric patients
Ashley Elizabeth Rosko • 1 Jun 2019

Related Videos

2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
2:25
Biomarkers of progression and risk stratification in asymptomatic Waldenström's macroglobulinemia
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals